Login Register Cart 0
Generic placeholder image

Current Drug Research Reviews

Editor-in-Chief

ISSN (Print): 2589-9775
ISSN (Online): 2589-9783

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Research Article

Assessing the Efficacy of Berberine Hydrochloride-loaded Transethosomal Gel System in Treating Dermatophytosis Caused by Trichophyton rubrum in ex-vivo, in-vitro and in-vivo Models

Author(s): Koushlesh Kumar Mishra, Chanchal Deep Kaur*, Sunil Singh, Abhishek Tiwari*, Varsha Tiwari and Ajay Sharma

Volume 16, Issue 3, 2024

Published on: 15 August, 2023

Page: [412 - 422] Pages: 11

DOI: 10.2174/2589977515666230726151456

Price: $65

conference banner
Abstract

Background: Dermatophytosis is the most common dermatological disorder worldwide. Many drugs are available in the market for the treatment of dermatophytosis, but they have had limited success due to the stratum corneum barrier, antifungal resistance, drug permeation, drug retention in skin layers, etc. Thus, there is a constant need for new topical compounds that are effective against dermatophytosis. Berberine-hydrochloride is an attractive candidate to become an antifungal drug, and by using nanotechnology, it achieves deeper penetration in skin layers with enhanced permeability through the stratum corneum.

Methods: In this study, we developed an oleic acid-containing berberine-hydrochloride-loaded transethosomal gel for effective treatment of dermatophytosis by Trichophyton rubrum. Berberine- hydrochloride-loaded transethosomal gels were fabricated using the hot homogenization method, followed by the incorporation of transethosomes into the gel-based system using carbopol 934. Transethosomal gel was characterized by physicochemical properties, in vitro drug release, ex-vivo permeation studies, CLSM visualization, antifungal activity, histopathological evaluation, and dermatokinetic study.

Results: Berberine-hydrochloride-loaded transethosomes seemed to be spherical and found in a range between 200-300 nm. Berberine-hydrochloride-loaded transethosomal gel formulation also exhibited controlled ex-vivo permeation of berberine-hydrochloride over 24 hr through excised rat skin, and CLSM confirmed deeper penetration into skin layers. The in vivo study revealed that transethosomal gel had a healing effect on the skin of Wistar rats infected with Trichophyton rubrum and was better than luliconazole cream. The histopathological evaluation confirmed its safety, and the dermatokinetic study showed transethosomal gel superiority over marketed cream.

Conclusion: Therefore, the incorporation of berberine hydrochloride-loaded transethosomal nanosystems into the gel has the potential to enhance antifungal activity and permeation through transdermal drug delivery.

Keywords: Berberine-hydrochloride, dermatophytosis, transethosomal gel, Trichophyton rubrum, antifungal, nanotechnology.

« Previous Next »
Graphical Abstract

[1]
Verma SB, Panda S, Nenoff P, et al. The unprecedented epidemic-like scenario of dermatophytosis in India: I. Epidemiology, risk factors and clinical features. Indian J Dermatol Venereol Leprol 2021; 87(2): 154-75.
[http://dx.doi.org/10.25259/IJDVL_301_20] [PMID: 33769736]
[2]
Nweze EI, Eke IE. Dermatophytes and dermatophytosis in the eastern and southern parts of Africa. Med Mycol 2017; 0: 1-17.
[PMID: 28419352]
[3]
Smith MB, McGinnis MR. Tropical Infectious Diseases: Principles, Pathogens and practice. (3rd ed.), Saunders Elsevier 2011.
[4]
Nweze EI, Eke I. Dermatophytosis in northern Africa. Mycoses 2016; 59(3): 137-44.
[http://dx.doi.org/10.1111/myc.12447] [PMID: 26692117]
[5]
Al Sheikh H. Epidemiology of dermatophytes in the eastern province of Saudi Arabia. Res J Microbiol 2009; 4(6): 229-34.
[http://dx.doi.org/10.3923/jm.2009.229.234]
[6]
AL-Khikani FO, Ayit A. Major challenges in dermatophytosis treatment: Current options and future visions. Egypt J Dermatol Venerol 2021; 41(1): 1-9.
[http://dx.doi.org/10.4103/ejdv.ejdv_23_20]
[7]
Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 2008; 22(8): 999-1012.
[http://dx.doi.org/10.1002/ptr.2399] [PMID: 18618524]
[8]
Zhu L, Zhang D, Zhu H, et al. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe−/− mice. Atherosclerosis 2018; 268: 117-26.
[http://dx.doi.org/10.1016/j.atherosclerosis.2017.11.023] [PMID: 29202334]
[9]
Zhang SL, Chang JJ, Damu GLV, et al. Novel berberine triazoles: Synthesis, antimicrobial evaluation and competitive interactions with metal ions to Human Serum Albumin. Bioorg Med Chem Lett 2013; 23(4): 1008-12.
[http://dx.doi.org/10.1016/j.bmcl.2012.12.036] [PMID: 23312473]
[10]
Choudhry VP, Sabir M, Bhide VN. Berberine in giardiasis. Indian Pediatr 1972; 9(3): 143-6.
[PMID: 4555485]
[11]
Swabb EA, Tai YH, Jordan L. Reversal of cholera toxin-induced secretion in rat ileum by luminal berberine. Am J Physiol 1981; 241(3): G248-52.
[PMID: 7282933]
[12]
Lin TH, Kuo HC, Chou FP, Lu FJ. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer 2008; 8(1): 58.
[http://dx.doi.org/10.1186/1471-2407-8-58] [PMID: 18294404]
[13]
Sun Y, Xun K, Wang Y, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 2009; 20(9): 757-69.
[http://dx.doi.org/10.1097/CAD.0b013e328330d95b] [PMID: 19704371]
[14]
Pang B, Zhao LH, Zhou Q, et al. Application of berberine on treating type 2 diabetes mellitus. Int J Endocrinol 2015; 2015: 1-12.
[http://dx.doi.org/10.1155/2015/905749] [PMID: 25861268]
[15]
Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004; 10(12): 1344-51.
[http://dx.doi.org/10.1038/nm1135] [PMID: 15531889]
[16]
Fatehi-Hassanabad Z, Jafarzadeh M, Tarhini A, Fatehi M. The antihypertensive and vasodilator effects of aqueous extract fromBerberis vulgaris fruit on hypertensive rats. Phytother Res 2005; 19(3): 222-5.
[http://dx.doi.org/10.1002/ptr.1661] [PMID: 15934023]
[17]
Mishra KK, Kaur CD, Sahu AK, Panik R, Kashyap P, Mishra SP. Medicinal plants having antifungal properties. Intechopen: EPublishing Inc 2020; pp. 1-14.
[18]
Peng L, Kang S, Yin Z, et al. Antibacterial activity and mechanism of berberine against Streptococcus agalactiae. Int J Clin Exp Pathol 2015; 8(5): 5217-23.
[PMID: 26191220]
[19]
Singh N, Sharma B. Toxicological effects of berberine and sanguinarine. Front Mol Biosci 2018; 5(21): 21.
[http://dx.doi.org/10.3389/fmolb.2018.00021] [PMID: 29616225]
[20]
Ashtikar M, Nagarsekar K, Fahr A. Transdermal delivery from liposomal formulations – Evolution of the technology over the last three decades. J Control Release 2016; 242: 126-40.
[http://dx.doi.org/10.1016/j.jconrel.2016.09.008] [PMID: 27620074]
[21]
Tanner T, Marks R. Delivering drugs by the transdermal route: Review and comment. Skin Res Technol 2008; 14(3): 249-60.
[http://dx.doi.org/10.1111/j.1600-0846.2008.00316.x] [PMID: 19159369]
[22]
Mishra KK, Kaur CD, Verma S, Sahu AK, Kashyap P, Mishra SP. Transethosomes and nanoethosomes: Recent approach on transdermal drug delivery system. In: Akhyar FM, Ed. Nanomedicines,. Intechopen: E-Publishing Inc. intechopen 2019; pp. 33-50.
[http://dx.doi.org/10.5772/intechopen.81152]
[23]
Song CK, Balakrishnan P, Shim CK, Chung SJ, Chong S, Kim DD. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: Characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces 2012; 92: 299-304.
[http://dx.doi.org/10.1016/j.colsurfb.2011.12.004] [PMID: 22205066]
[24]
Hoang H, Hoai PP, Quang TT. Development of Itraconazole-loaded polymeric nanoparticle dermal gel for enhanced antifungal efficacy. J Nanomater 2020; 2020: 1-11.
[http://dx.doi.org/10.1155/2020/3207909]
[25]
Nguyen CN, Nguyen TTT, Nguyen HT, Tran TH. Nanostructured lipid carriers to enhance transdermal delivery and efficacy of diclofenac. Drug Deliv Transl Res 2017; 7(5): 664-73.
[http://dx.doi.org/10.1007/s13346-017-0415-2] [PMID: 28776220]
[26]
Shimamura T, Kubota N, Shibuya K. Animal model of dermatophytosis. J Biomed Biotechnol 2012; 2012: 1-11.
[http://dx.doi.org/10.1155/2012/125384] [PMID: 22619489]
[27]
Albash R, Abdelbary A, Refai H, El-Nabarawi M. Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: In vitro, ex vivo, and in vivo evaluation. Int J Nanomedicine 2019; 14: 1953-68.
[http://dx.doi.org/10.2147/IJN.S196771] [PMID: 30936696]
[28]
Utreja P, Kumar L. Formualtion and Characterization of transethosomes for enhanced transdermal delivery of Propranolol hydrochloride. Micro Nanosyst 2019; 11(2): 1-10.
[29]
Song X, Wei YX, Lai KM, He ZD, Zhang HJ. In vivo antifungal activity of dipyrithione against Trichophyton rubrum on guinea pig dermatophytosis models. Biomed Pharmacother 2018; 108: 558-64.
[http://dx.doi.org/10.1016/j.biopha.2018.09.045] [PMID: 30243089]
[30]
Koga H. [Animal model for superficial mycosis]. Nippon Ishinkin Gakkai Zasshi 2009; 50(2): 085-9.
[http://dx.doi.org/10.3314/jjmm.50.085] [PMID: 19430182]
[31]
Moolakkadath T, Aqil M, Ahad A, et al. Development of transethosomes formulation for dermal fisetin delivery: Box–Behnken design, optimization, in vitro skin penetration, vesicles–skin interaction and dermatokinetic studies. Artif Cells Nanomed Biotechnol 2018; 46(S2): 755-65.
[http://dx.doi.org/10.1080/21691401.2018.1469025] [PMID: 29730964]
[32]
Aziz DE, Abdelbary AA, Elassasy AI. Investigating superiority of novel bilosomes over niosomes in the transdermal delivery of diacerein: In vitro characterization, ex vivo permeation and in vivo skin deposition study. J Liposome Res 2019; 29(1): 73-85.
[http://dx.doi.org/10.1080/08982104.2018.1430831] [PMID: 29355060]

Rights & Permissions Print Cite
Article Metrics
15
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy